Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan bioequivalence study in healthy adults
NCT07278349Phase 1Completed
- Sponsor
- Humanis
- Start
- Sep 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vonoprazan (2 arms), sponsored by Humanis. Primary endpoints: Maximal Plasma Concentration at 48 hours and Area Under the Plasma Concentration-Time Curve from Zero to Time t at 48 hours. Started Sep 2025; status: completed.
02
Drugs
vonoprazan
Beyond the preview
Go deeper on NCT07278349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07278349.